By subjecting USP19 knockout mice to angiotensin II (AngII) stimuli or cardiac pressure overload, which was performed by transverse aortic constriction (TAC), the USP19 deficiency exacerbated the cardiac hypertrophy, fibrosis, dysfunction and inflammation. This evidence concerns the gene USP19 and cardiac hypertrophy.